$MDAI
Spectral AI, Inc.

2024 Q4 Form 10-Q Financial Statement

#000121390024095006 Filed on November 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $8.173M
YoY Change 137.59%
Cost Of Revenue $4.506M
YoY Change 128.96%
Gross Profit $3.667M
YoY Change 149.12%
Gross Profit Margin 44.87%
Selling, General & Admin $4.553M
YoY Change -19.24%
% of Gross Profit 124.16%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.000K
YoY Change -71.43%
% of Gross Profit 0.05%
Operating Expenses $4.553M
YoY Change -19.24%
Operating Profit -$886.0K
YoY Change -78.73%
Interest Expense -$17.00K
YoY Change -194.44%
% of Operating Profit
Other Income/Expense, Net -$581.0K
YoY Change -91.08%
Pretax Income -$1.467M
YoY Change -86.27%
Income Tax $37.00K
% Of Pretax Income
Net Earnings -$1.504M
YoY Change -85.85%
Net Earnings / Revenue -18.4%
Basic Earnings Per Share -$0.08
Diluted Earnings Per Share -$0.08
COMMON SHARES
Basic Shares Outstanding 18.59M shares 17.61M shares
Diluted Shares Outstanding 17.86M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.702M
YoY Change -49.62%
Cash & Equivalents $3.702M
Short-Term Investments
Other Short-Term Assets $1.011M
YoY Change 70.2%
Inventory $443.0K
Prepaid Expenses $1.506M
Receivables $2.834M
Other Receivables $0.00
Total Short-Term Assets $9.496M
YoY Change -16.38%
LONG-TERM ASSETS
Property, Plant & Equipment $5.000K
YoY Change -64.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.106M
YoY Change 116.0%
TOTAL ASSETS
Total Short-Term Assets $9.496M
Total Long-Term Assets $2.106M
Total Assets $11.60M
YoY Change -5.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.797M
YoY Change -14.6%
Accrued Expenses $3.253M
YoY Change -18.33%
Deferred Revenue $731.0K
YoY Change
Short-Term Debt $4.974M
YoY Change 687.03%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.07M
YoY Change 22.74%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $2.870M
YoY Change 1158.77%
Total Long-Term Liabilities $2.870M
YoY Change 1158.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.07M
Total Long-Term Liabilities $2.870M
Total Liabilities $15.94M
YoY Change 46.56%
SHAREHOLDERS EQUITY
Retained Earnings -$40.40M
YoY Change 38.16%
Common Stock $2.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.336M
YoY Change
Total Liabilities & Shareholders Equity $11.60M
YoY Change -5.91%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$1.504M
YoY Change -85.85%
Depreciation, Depletion And Amortization $2.000K
YoY Change -71.43%
Cash From Operating Activities -$1.626M
YoY Change -84.49%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.564M
YoY Change -138.72%
NET CHANGE
Cash From Operating Activities -1.626M
Cash From Investing Activities
Cash From Financing Activities -1.564M
Net Change In Cash -3.190M
YoY Change -50.51%
FREE CASH FLOW
Cash From Operating Activities -$1.626M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q4 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q3 mdai Borrowing Related Costs
BorrowingRelatedCosts
usd
mdai Borrowing Related Costs
BorrowingRelatedCosts
usd
CY2023Q3 mdai Fair Value Adjustment Of Notes Payable
FairValueAdjustmentOfNotesPayable
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
SPECTRAL AI, INC.
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-3987148
dei Entity Address Address Line1
EntityAddressAddressLine1
2515 McKinney Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1000
dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75201
dei City Area Code
CityAreaCode
(972)
dei Local Phone Number
LocalPhoneNumber
499-4934
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18588073 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3702000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4790000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2834000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2346000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
443000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
230000 usd
CY2023Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
283000 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1506000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1452000 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1011000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
801000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
9496000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
9902000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2101000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
778000 usd
CY2024Q3 us-gaap Assets
Assets
11602000 usd
CY2023Q4 us-gaap Assets
Assets
10692000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2797000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2683000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3253000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4300000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
731000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2311000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
212000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
853000 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
597000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
436000 usd
CY2024Q3 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
4377000 usd
CY2024Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1101000 usd
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1818000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
13068000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12401000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1870000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
15938000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
12401000 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18513073 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18513073 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16294935 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16294935 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
2000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
35998000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31065000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
25000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
12000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40361000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32788000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-4336000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1709000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11602000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10692000 usd
CY2024Q3 us-gaap Revenues
Revenues
8173000 usd
CY2023Q3 us-gaap Revenues
Revenues
3440000 usd
us-gaap Revenues
Revenues
21977000 usd
us-gaap Revenues
Revenues
12769000 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
4506000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
1968000 usd
us-gaap Cost Of Revenue
CostOfRevenue
12051000 usd
us-gaap Cost Of Revenue
CostOfRevenue
7325000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
3667000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
1472000 usd
us-gaap Gross Profit
GrossProfit
9926000 usd
us-gaap Gross Profit
GrossProfit
5444000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4553000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5638000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15397000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15499000 usd
CY2024Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4553000 usd
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
5638000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
15397000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
15499000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-886000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4166000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5471000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10055000 usd
CY2024Q3 us-gaap Investment Income Net
InvestmentIncomeNet
-8000 usd
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
42000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
128000 usd
CY2024Q3 mdai Borrowing Related Costs
BorrowingRelatedCosts
1059000 usd
mdai Borrowing Related Costs
BorrowingRelatedCosts
2034000 usd
CY2024Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-350000 usd
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1069000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-718000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1004000 usd
CY2024Q3 mdai Fair Value Adjustment Of Notes Payable
FairValueAdjustmentOfNotesPayable
-94000 usd
mdai Fair Value Adjustment Of Notes Payable
FairValueAdjustmentOfNotesPayable
7000 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-9000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-24000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-34000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-11000 usd
CY2024Q3 mdai Transaction Costs Incurred In Connection With Warrant Liabilities
TransactionCostsIncurredInConnectionWithWarrantLiabilities
-51000 usd
CY2023Q3 mdai Transaction Costs Incurred In Connection With Warrant Liabilities
TransactionCostsIncurredInConnectionWithWarrantLiabilities
7604000 usd
mdai Transaction Costs Incurred In Connection With Warrant Liabilities
TransactionCostsIncurredInConnectionWithWarrantLiabilities
617000 usd
mdai Transaction Costs Incurred In Connection With Warrant Liabilities
TransactionCostsIncurredInConnectionWithWarrantLiabilities
8342000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-581000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6517000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1974000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7221000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1467000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10683000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7445000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17276000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-54000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
128000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1504000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10629000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7573000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17308000 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.77
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.77
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.29
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17862240 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17862240 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13822990 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13822990 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17342203 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17342203 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13410287 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13410287 shares
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
15000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-3000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
13000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1489000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10632000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7560000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17308000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1709000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
283000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2605000 usd
CY2024Q1 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-2000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3205000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-2028000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
402000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
225000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-2864000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-4265000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
173000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1245000 usd
CY2024Q3 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
15000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1504000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-4336000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11996000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
300000 usd
CY2023Q1 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
1000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3609000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
8688000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
396000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6000 usd
CY2023Q2 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
2000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3070000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
6022000 usd
CY2023Q3 mdai Adjustments To Additional Paid In Capital Issuance Of Common Stock Upon Business Combination
AdjustmentsToAdditionalPaidInCapitalIssuanceOfCommonStockUponBusinessCombination
-2374000 usd
CY2023Q3 mdai Adjustments To Additional Paid In Capital Accounts Payable
AdjustmentsToAdditionalPaidInCapitalAccountsPayable
150000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1800000 usd
CY2023Q3 mdai Stock Issued During Period Value Commitment To Issue Shares For Transaction Costs
StockIssuedDuringPeriodValueCommitmentToIssueSharesForTransactionCosts
2550000 usd
CY2023Q3 mdai Adjustments To Additional Paid In Capital Private Placement Equity Issuance
AdjustmentsToAdditionalPaidInCapitalPrivatePlacementEquityIssuance
3351000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
279000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
310000 usd
CY2023Q3 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-3000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10629000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1456000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7573000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17308000 usd
us-gaap Depreciation
Depreciation
7000 usd
us-gaap Depreciation
Depreciation
7000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
858000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
975000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-448000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-530000 usd
mdai Issuance Of Shares For Transaction Costs
IssuanceOfSharesForTransactionCosts
1800000 usd
mdai Commitment To Issue Shares For Transaction Costs
CommitmentToIssueSharesForTransactionCosts
2550000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-718000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1004000 usd
mdai Change In Fair Values Of Notes Payable
ChangeInFairValuesOfNotesPayable
-7000 usd
mdai Costs From Issuance Of Common Stock
CostsFromIssuanceOfCommonStock
372000 usd
mdai Issuance Of Shares For Borrowing Related Costs
IssuanceOfSharesForBorrowingRelatedCosts
280000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
488000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-982000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
213000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
220000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-491000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-542000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
469000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
208000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
197000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
188000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-554000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1047000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1225000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1580000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
795000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-542000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-468000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9668000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10865000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2667000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3351000 usd
mdai Cash Received In Business Combination
CashReceivedInBusinessCombination
-660000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
11500000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1000000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
6600000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
288000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
316000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8567000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4039000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1088000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6826000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4790000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14174000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3702000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7348000 usd
us-gaap Interest Paid Net
InterestPaidNet
6000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
20000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
114000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1771000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
483000 usd
mdai Broker Receivable For Stock Option Exercises
BrokerReceivableForStockOptionExercises
3034000 usd
mdai Prepaid Asset Acquired Net Of Cancellation For Debt And Accounts Payable
PrepaidAssetAcquiredNetOfCancellationForDebtAndAccountsPayable
596000 usd
mdai Prepaid Asset Acquired Net Of Cancellation For Debt And Accounts Payable
PrepaidAssetAcquiredNetOfCancellationForDebtAndAccountsPayable
955000 usd
mdai Issuance Of Common Stock To Settle Accounts And Notes Payable
IssuanceOfCommonStockToSettleAccountsAndNotesPayable
1245000 usd
mdai Issuance Of Common Stock To Settle Accounts And Notes Payable
IssuanceOfCommonStockToSettleAccountsAndNotesPayable
150000 usd
CY2023Q3 mdai Common Stock Exchange Ratio Price
CommonStockExchangeRatioPrice
10.31
CY2023Q3 mdai Contract Value
ContractValue
150000000 usd
CY2024Q3 mdai Contract Inital Award Value
ContractInitalAwardValue
54900000 usd
mdai Contract Initial Award Remaining Value
ContractInitialAwardRemainingValue
30000000 usd
CY2023Q2 us-gaap Amount Of Regulatory Assistance Received1
AmountOfRegulatoryAssistanceReceived1
4000000 usd
CY2024Q3 mdai Award Value Increased
AwardValueIncreased
4900000 usd
CY2024Q3 mdai Additional Development Amount
AdditionalDevelopmentAmount
900000 usd
CY2024Q1 us-gaap Investment Company Increase From Payment By Affiliate And Gain Loss From Investment In Violation
InvestmentCompanyIncreaseFromPaymentByAffiliateAndGainLossFromInvestmentInViolation
1000000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40400000 usd
CY2024Q3 us-gaap Other Notes Payable
OtherNotesPayable
5000000 usd
CY2023Q4 us-gaap Other Notes Payable
OtherNotesPayable
400000 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
1000000 usd
CY2023Q4 mdai Aggregate Gross Purchase Price
AggregateGrossPurchasePrice
10000000 usd
CY2024Q1 us-gaap Program Rights Obligations
ProgramRightsObligations
30000000 usd
CY2024Q3 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
3000000 usd
CY2024Q2 us-gaap Marketable Securities
MarketableSecurities
35000000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. The Company bases its estimates and judgments on historical experience and on various other assumptions that it believes are reasonable under the circumstances. The amounts of assets and liabilities reported in the Company’s balance sheets and the amounts of expenses reported for each of the periods presented are affected by estimates and assumptions, which are used for, but not limited to, revenue recognition, warrant liabilities, the fair value of short term notes payable, fair value of the B. Riley and Yorkville derivative instruments, stock-based compensation expense, stock issued for transaction costs, the net realizable value of inventory, right-of-use assets, and income tax valuation allowances. Actual results could differ from these estimates.</span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b><i>Concentrations of Credit Risk</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Financial instruments which potentially subject the Company to credit risk consist principally of cash and accounts receivable. Primarily all cash is held in US financial institutions which, at times, exceed federally insured limits. The Company has not recognized any losses from credit risks on such accounts. The Company believes it is not exposed to significant credit risk on cash.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Additional credit risk is related to the Company’s concentration of receivables. As of September 30, 2024 and December 31, 2023, receivables were concentrated from one customer (which is a US. Government agency) representing 98% and 92% of total net receivables, respectively. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>One customer (which is a U.S. government agency) accounted for 90% and 93% for the three and nine months ended September 30, 2024, respectively and 89% and 94% for the three and nine months ended September 30, 2023, respectively of the recognized research and development revenue.</span></p>
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
9000000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
34000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
24000000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
11000000 usd
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.5
CY2023Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2024Q3 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
5200000 usd
CY2023Q3 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
3600000 usd
CY2024Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
700000 usd
CY2023Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1600000 usd
us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
14900000 usd
us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
11300000 usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
2900000 usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
4000000 usd
CY2024Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
2400000 usd
CY2024Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
660000 usd
CY2024Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
127000 usd
CY2024Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
860000 usd
CY2024Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
277000 usd
CY2024Q3 mdai Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Warrant Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiabilities
2024000 usd
CY2024Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
-2374000 usd
CY2024Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
660000 usd
CY2024Q3 mdai Noncash Net Assets Assumed In Exchange For Common Stock
NoncashNetAssetsAssumedInExchangeForCommonStock
-3034000 usd
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
200000 usd
CY2023Q4 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
1900000 usd
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
47000 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-20000 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
27000 usd
CY2024Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-11000 usd
CY2024Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
16000 usd
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-12000 usd
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4000 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
129000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-16000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
113000 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
81000 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
194000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-141000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
53000 usd
CY2024Q1 mdai Addition Of Shortterm Notes Payable
AdditionOfShorttermNotesPayable
4600000 usd
CY2024Q1 mdai Change In Fair Value Of Notes Payable
ChangeInFairValueOfNotesPayable
66000 usd
CY2024Q1 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
4534000 usd
CY2024Q2 mdai Addition Of Shortterm Notes Payable
AdditionOfShorttermNotesPayable
4600000 usd
CY2024Q2 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
2300000 usd
CY2024Q2 mdai Change In Fair Value Of Notes Payable
ChangeInFairValueOfNotesPayable
-167000 usd
CY2024Q2 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
7001000 usd
CY2024Q3 mdai Addition Of Shortterm Notes Payable
AdditionOfShorttermNotesPayable
2300000 usd
CY2024Q3 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
4830000 usd
CY2024Q3 mdai Change In Fair Value Of Notes Payable
ChangeInFairValueOfNotesPayable
94000 usd
CY2024Q3 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
4377000 usd
CY2024Q3 us-gaap Revenues
Revenues
8173000 usd
CY2023Q3 us-gaap Revenues
Revenues
3440000 usd
us-gaap Revenues
Revenues
21977000 usd
us-gaap Revenues
Revenues
12769000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2311000 usd
us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
4238000 usd
mdai Contract With Customer Liability Reductions
ContractWithCustomerLiabilityReductions
5818000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
731000 usd
CY2024Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1957000 usd
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1910000 usd
CY2024Q3 mdai Accrued Operating Expenses
AccruedOperatingExpenses
504000 usd
CY2023Q4 mdai Accrued Operating Expenses
AccruedOperatingExpenses
1563000 usd
CY2024Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
517000 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
720000 usd
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
215000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
107000 usd
CY2024Q3 mdai Accrued Borrowing Related Costs Current
AccruedBorrowingRelatedCostsCurrent
60000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3253000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4300000 usd
us-gaap Debt Instrument Repaid Principal
DebtInstrumentRepaidPrincipal
7565000 usd
us-gaap Debt Instrument Repaid Principal
DebtInstrumentRepaidPrincipal
288000 usd
CY2024Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
5974000 usd
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
436000 usd
CY2024Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
30000000 usd
CY2024Q1 us-gaap Debt Instrument Issued Principal
DebtInstrumentIssuedPrincipal
12500000 usd
CY2024Q1 us-gaap Cash
Cash
4600000 usd
CY2024Q1 mdai Discount Rate
DiscountRate
0.08 pure
CY2024Q1 mdai Percentage Of Prepaid Advance
PercentageOfPrepaidAdvance
0.92 pure
CY2024Q1 mdai Percentage Of Prepaid Advance At Annual Rate
PercentageOfPrepaidAdvanceAtAnnualRate
0 pure
CY2024Q1 mdai Percentage Of Increase In Convertible Notes
PercentageOfIncreaseInConvertibleNotes
0.18 pure
mdai Installment Principal Amount
InstallmentPrincipalAmount
750000 usd
mdai Installment Premium Rate
InstallmentPremiumRate
0.07 pure
mdai Repayment Of Debt Value Settled In Shares
RepaymentOfDebtValueSettledInShares
1100000 usd
CY2024Q3 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
200000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
800000 usd
CY2024Q3 us-gaap Tenant Improvements
TenantImprovements
300000 usd
CY2024Q3 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P12M
CY2024Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
232000 usd
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
208000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
662000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
536000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1771000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
483000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M24D
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y3M18D
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M24D
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y3M18D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.085 pure
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.085 pure
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.085 pure
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.085 pure
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
182000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
205000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
569000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
597000 usd
CY2024Q3 us-gaap Variable Lease Cost
VariableLeaseCost
119000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
92000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
288000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
256000 usd
CY2024Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
301000 usd
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
297000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
857000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
853000 usd
CY2024Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
38000 usd
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
41000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
116000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
69000 usd
CY2024Q3 mdai Lease And Rental Expenses
LeaseAndRentalExpenses
339000 usd
CY2023Q3 mdai Lease And Rental Expenses
LeaseAndRentalExpenses
338000 usd
mdai Lease And Rental Expenses
LeaseAndRentalExpenses
973000 usd
mdai Lease And Rental Expenses
LeaseAndRentalExpenses
922000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
232000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
691000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
850000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
871000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
149000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2793000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
384000 usd
CY2024Q3 mdai Tenant Improvement Allowance
TenantImprovementAllowance
-327000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2082000 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
400000 usd
mdai Service Fee Costs
ServiceFeeCosts
100000 usd
CY2024Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
30000000 usd
CY2024Q1 mdai Pre Paid Advance Disbursed Amount
PrePaidAdvanceDisbursedAmount
4600000 usd
CY2024Q1 mdai Prepaid Advance Net Discount Amount
PrepaidAdvanceNetDiscountAmount
400000 usd
CY2024Q1 mdai Prepaid Advance Net Discount Percentage
PrepaidAdvanceNetDiscountPercentage
0.08 pure
CY2024Q2 us-gaap Prepaid Interest
PrepaidInterest
5000000 usd
CY2024Q2 mdai Prepaid Advance Net Discount Amount
PrepaidAdvanceNetDiscountAmount
400000 usd
CY2024Q2 mdai Prepaid Advance Net Discount Percentage
PrepaidAdvanceNetDiscountPercentage
0.08 pure
CY2024Q3 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
3000000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
8000000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue
12
CY2024Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
600000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
58197 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
2.16
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
4.65
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
1.76
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.44
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y7M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.66 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.72 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.043 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.035 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3598944 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.2
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y6M
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8087000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
443437 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.76
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
133441 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.07
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
122749 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
4.54
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3786191 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.99
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M6D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
18000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
3186977 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.79
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y7M6D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
18000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
128000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-54000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32000 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.025 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.017 pure
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.005 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.002 pure
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12762902 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13084703 shares
CY2024Q1 us-gaap Advances To Affiliate
AdvancesToAffiliate
1000000 usd
CY2024Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
0.08 pure
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
us-gaap Investment Income Net
InvestmentIncomeNet
usd
mdai Fair Value Adjustment Of Notes Payable
FairValueAdjustmentOfNotesPayable
usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
usd
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2024Q2 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
usd
mdai Issuance Of Shares For Transaction Costs
IssuanceOfSharesForTransactionCosts
usd
mdai Commitment To Issue Shares For Transaction Costs
CommitmentToIssueSharesForTransactionCosts
usd
mdai Change In Fair Values Of Notes Payable
ChangeInFairValuesOfNotesPayable
usd
mdai Costs From Issuance Of Common Stock
CostsFromIssuanceOfCommonStock
usd
mdai Issuance Of Shares For Borrowing Related Costs
IssuanceOfSharesForBorrowingRelatedCosts
usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
usd
mdai Cash Received In Business Combination
CashReceivedInBusinessCombination
usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
mdai Broker Receivable For Stock Option Exercises
BrokerReceivableForStockOptionExercises
usd
CY2023Q4 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
usd
CY2023Q4 mdai Accrued Borrowing Related Costs Current
AccruedBorrowingRelatedCostsCurrent
usd
CY2024Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2023Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001833498
dei Entity File Number
EntityFileNumber
000-00000

Files In Submission

Name View Source Status
mdai-20240930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001213900-24-095006-index-headers.html Edgar Link pending
0001213900-24-095006-index.html Edgar Link pending
0001213900-24-095006.txt Edgar Link pending
0001213900-24-095006-xbrl.zip Edgar Link pending
ea0219007-10q_spectral.htm Edgar Link pending
ea021900701ex31-1_spectral.htm Edgar Link pending
ea021900701ex31-2_spectral.htm Edgar Link pending
ea021900701ex32_spectral.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mdai-20240930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
mdai-20240930_cal.xml Edgar Link unprocessable
mdai-20240930_lab.xml Edgar Link unprocessable
mdai-20240930_pre.xml Edgar Link unprocessable
ea0219007-10q_spectral_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending